Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Sheth, T. Articles by Kucharczyk, Search for Related Content PubMed PubMed Citation Articles by Sheth, T. Articles by Kucharczyk,

American Journal of Neuroradiology 20:853-856 (5 1999)
© 1999 American Society of Neuroradiology

ARTICLE

Brain Perfusion Imaging in Asymptomatic Patients Receiving Cyclosporin

Tarang N. Sheth^a, Masanori Ichise^a and Walter Kucharczyk^,a

^a From the Department of Medical Imaging, The Toronto Hospital and University of Toronto (T.N.S., W.K.); and the Department of Medical Imaging, Mount Sinai Hospital and University of Toronto (M.I.).

BACKGROUND AND PURPOSE: Cyclosporin has neurotoxic effects in a significant number of transplant patients that are associated with characteristic findings on MR images. Focal abnormalities in cerebral perfusion have been implicated in the pathophysiology of cyclosporin neurotoxicity. In the clinically asymptomatic patient, however, it is not known whether any imaging evidence of cyclosporin's effect on the brain is demonstrable. Our hypothesis was that conventional MR imaging, perfusion MR imaging, and single-photon emission CT (SPECT) could enable detection of subclinical lesions in asymptomatic patients. The ability to detect such lesions might aid in the identification of persons most at risk for clinical neurotoxicity.

METHODS: Ten posttransplant patients being treated with cyclosporin were recruited prospectively. Imaging studies were performed within 3 weeks of transplantation. Patients were examined with MR imaging, using standard spin-echo and dynamic contrast-enhanced perfusion techniques, and SPECT scanning. Postprocessing of MR perfusion data was performed to obtain pixel-by-pixel maps of regional cerebral blood volume, peak height, and time-to-peak parameters.

RESULTS: The mean age of the patients was 45 ± 11 years. At the time of imaging, three patients had minor neurologic manifestations commonly associated with cyclosporin (ie, mild tremor, headache), but no patient had clinical neurotoxicity. Findings on conventional MR images, MR perfusion maps, and SPECT perfusion scans were normal in all patients.

CONCLUSION: Conventional MR imaging, dynamic perfusion MR imaging, and SPECT do not depict any lesions in asymptomatic patients on cyclosporin. Therefore, it may not be possible for imaging methods to aid in the identification of patients at risk for neurotoxicity. Our findings support previously published conclusions that the lesions visible in patients with clinical neurotoxicity are due to cyclosporin effects and not to preexisting coincidental abnormalities.

This article has been cited by other articles:

				E. M. Sklar Post-transplant Neurotoxicity: What Role do Calcineurin Inhibitors Actually Play? AJNR Am. J. Neuroradiol., September 1, 2006; 27(8): 1602 - 1603. [Full Text] [PDF]

				N. J. Serkova, U. Christians, and L. Z. Benet Biochemical Mechanisms of Cyclosporine Neurotoxicity Mol. Interv., April 1, 2004; 4(2): 97 - 107. [Abstract] [Full Text] [PDF]

				D. J. Covarrubias, P. H. Luetmer, and N. G. Campeau Posterior Reversible Encephalopathy Syndrome: Prognostic Utility of Quantitative Diffusion-Weighted MR Images AJNR Am. J. Neuroradiol., June 1, 2002; 23(6): 1038 - 1048. [Abstract] [Full Text] [PDF]